Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
2.110
-0.100 (-4.52%)
At close: Mar 6, 2026, 4:00 PM EST
2.100
-0.010 (-0.47%)
After-hours: Mar 6, 2026, 6:00 PM EST
Alpha Teknova Market Cap
Alpha Teknova has a market cap or net worth of $113.07 million as of March 6, 2026. Its market cap has decreased by -73.45% in one year.
Market Cap
113.07M
Enterprise Value
120.00M
1-Year Change
-73.45%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since the IPO on June 25, 2021, Alpha Teknova's market cap has decreased from $433.79M to $113.07M, a decrease of -73.93%. That is a compound annual growth rate of -24.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 113.07M | -44.41% |
| Dec 31, 2025 | 203.41M | -54.30% |
| Dec 31, 2024 | 445.12M | 193.01% |
| Dec 29, 2023 | 151.91M | -4.25% |
| Dec 30, 2022 | 158.66M | -72.34% |
| Dec 31, 2021 | 573.68M | 32.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Journey Medical | 267.38M |
| Lifecore Biomedical | 264.51M |
| BGM Group | 202.36M |
| Aurora Cannabis | 198.14M |
| Anika Therapeutics | 192.43M |
| Organigram Global | 184.72M |
| Cardiol Therapeutics | 113.64M |
| Citius Oncology | 96.22M |